Incidence of risk factors in developmental dysplasia of the hip: a retrospective study on 18,954 cases

Gaetano Caruso1,2, Edoardo Gambuti1,2, Elisa Spadoni1,2

  • 1Department of Neurosciences and Rehabilitation, University of Ferrara, Ferrara, Italy.

Insights

Female sex, family history, skeletal issues, oligohydramnios, and breech presentation are key risk factors for developmental dysplasia of the hip (DDH). Early identification and management are crucial for preventing childhood disability.

Area of Science:

  • Pediatric Orthopedics
  • Developmental Biology
  • Clinical Epidemiology

Background:

  • Developmental Dysplasia of the Hip (DDH) is a significant cause of childhood disability.
  • Neonatal diagnosis of hip instability can be achieved through Ortolani and Barlow maneuvers.
  • Clinical examination has high specificity but low sensitivity for DDH detection compared to ultrasound, leading to debate on universal versus selective screening.

Purpose of the Study:

  • To analyze the risk factors associated with congenital hip dysplasia in infants.
  • To identify key predictors for the development of DDH in a pediatric cohort.

Main Methods:

  • A cross-sectional study was conducted on 18,954 infants between January 2000 and December 2019.
  • Infants were classified using the Graf classification system, distinguishing between physiological (1A, 1B, 2A+) and pathological (2A-, 2B, 2C, 2D, 3, 4) types.
  • Statistical analysis identified significant risk factors, including odds ratios (OR) and 95% confidence intervals (CI).

Main Results:

  • Female infants constituted 56% of the study population.
  • The most significant risk factor identified was female gender (OR 5.36), followed by family history (OR 2.35), skeletal pathologies (OR 2.04), oligohydramnios (OR 1.75), and breech presentation (OR 1.42).
  • Prevalence rates for Graf classifications ranged from 1.0% for type 4 to 52.7% for type 1B.

Conclusions:

  • Female sex, family history, musculoskeletal diseases, oligohydramnios, and breech presentation are identified as primary risk factors for DDH.
  • These findings underscore the importance of considering these factors in the diagnosis and management of DDH.
  • Understanding these risk factors can aid in targeted screening and early intervention strategies for DDH.
Abstract

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Odds Ratio01:09

Odds Ratio

The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...